How has the survival rate for young adults with cancer changed over the past two decades?

Over the past 20 years, survival rates for young adults with cancer have shown significant but uneven improvement. While overall 5-year survival for this age group (15-39) has increased from approximately 80% in the early 2000s to around 85-87% today, progress varies dramatically by cancer type. Hematologic cancers like Hodgkin lymphoma and testicular cancer now have survival rates exceeding 95%, representing major advances. However, survival improvements for other common young adult cancers like sarcomas, brain tumors, and certain leukemias have been more modest, with increases of just 5-10 percentage points. This disparity reflects both biological differences in tumor behavior and historical underinvestment in age-specific research. The growing population of young adult survivors—now estimated at nearly 500,000 in developed countries—creates new challenges for healthcare systems that must address their unique long-term needs. Importantly, survival gains haven't been equal across demographics, with persistent gaps based on socioeconomic status, race, and geographic location that continue to limit overall progress.

📖 Read the full article: Steeds meer jongvolwassenen leven met gevolgen van kanker - Metronieuws.nl